Use of Psychotropic Medications: State and Local Examples
Examples of State policies, guidelines, and information regarding the use of psychotropic medications for children and youth, with a focus on foster care.
Guidelines for Psychotropic Medication Use in Children and Adolescents (PDF - 56 KB)
Connecticut Department of Children and Families Psychotropic Medication Advisory Committee (2010)
Provides guidelines, based on clinical evidence, clinical judgment, and research, that represent a community standard in the use of psychotropic medications in children and adolescents under Connecticut DCF's care.
Legal Strategies to Challenge Chemical Restraint of Children in Foster Care: A Resource for Child Advocates in Florida (PDF - 126 KB)
Advocacy Center for Persons with Disabilities (2006)
Aims to help advocates educate dependency judges and protect children in foster care against rights violations, harmful drugs, and/or chemical restraint. This paper includes information about commonly prescribed psychotropic drugs, their side effects, and legal strategies for challenging harmful treatment and/or chemical restraint.
Medication Guidelines for Children
Florida Medicaid Drug Therapy Management Program for Behavioral Health
Provides medication guidelines for prescribers in the Medicaid program for children and adolescents.
Psychotropic Medication for Children in Out of Home Care
Florida's Center for the Advancement of Child Welfare Practice
Supplies Florida-specific, as well as other State and national, resources and information related to psychotropic medication. This website provides these resources under three areas: laws, rules, policy and reports; memos, tools, and training; and information on medication uses and side effects.
Statewide Guardian ad Litem Program Guidelines & Practice Aids
Florida Guardian ad Litem Program
Links to guidelines on psychotropic medications and other resources for Guardians ad Litem in Florida, including a psychotropic medication timeline, checklist, and chart outlining recommended doses, medication management, black box warnings, and other key information.
Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care (PDF - 26 KB)
Illinois Department of Children and Family Services
Provides a framework to assure the provision of quality psychiatric services to children in the custody of the Illinois Department of Children and Family Services.
Psychotropic Medication Policy (PDF - 239 KB)
New Jersey Department of Children and Family Services, Office of Child Health Services
Outlines good practice for treating New Jersey children in out of home care who may require psychotropic medications. The policy sets expectations regarding the development and monitoring of treatment plans and principles governing informed consent and medication safety.
Administrative Policies and Procedures: 20.18 Psychotropic Medication (PDF - 96 KB)
State of Tennessee Department of Children's Services (2011)
Provides policies and procedures to all DCS and contract provider caregivers regarding psychotropic medication for children and youth in State custody.
Psychotropic Medication Utilization Parameters for Children in State Custody (PDF - 57 KB)
Tennessee Department of Children's Services Pharmacy and Therapeutics Committee
Supplies guidance to ensure that psychotropic medications being prescribed for children and youth in foster care are done so in a safe and appropriate manner.
A Guide to Medical Services at CPS: Psychotropic Medications
Texas Department of Family and Protective Services
Provides a guide, Psychotropic Medication Utilization Parameters for Foster Children (PDF - 647 KB), for physicians and clinicians to ensure the proper use of psychotropic medications for the children in foster care. The website also provides information about "Psychotropic Medication Utilization Reviews" for foster children whose medication regimens fall outside of the expectations of the parameters.
Update on the Use of Psychoactive Medications in Texas Foster Children Fiscal Years 20022010 PDF - 154 KB)
Texas Health and Human Services Commission (2011)
Summarizes key information and provides an updated analysis showing psychotropic prescribing of all types has decreased since the implementation of best practice parameters in early 2005.